Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIsCOvER trial of dronabinol for chemotherapy- and tumor-related symptoms in advanced pancreatic cancer
2019-000616-28Phase 3Completed
- Sponsor
- AGMT
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pancreatic cancer (PC) comparing Dronabinol plus first-line chemotherapy with Placebo plus first-line chemotherapy (2 arms). Started Jun 2019; status: completed.
02
Drugs
dronabinol
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on 2019-000616-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000616-28.